Investing in biotechnology
Galenicum has invested in two major biotechnology projects: Bionure and Azurebio.
Based in Barcelona’s Parc Científic science park; new offices will soon be opened in San Francisco, California.
- Developing an NCE for multiple sclerosis.
- Potential applications in the treatment of neuro-degenerative diseases such as Alzheimer's and Parkinson's.